Abstract
Follicular carcinoma of the thyroid is one of the subgroups of differentiated thyroid carcinoma. This group also includes papillary carcinoma and the follicular variant of papillary carcinoma. Hürthle cell (oxyphil cell, Askanazy cell) carcinoma is now considered a subgroup of follicular carcinoma. Although these tumors are all generally slow growing, late to metastasize, and often associated with a normal life span, there are significant differences among them. This has produced much confusion in the literature, where authors have lumped them all together as “well-differentiated carcinoma” and have reported results of treatment in large series without regard for separating patients in terms of risk factors. Finally, there is great variability in length of follow up in a relatively slow growing lesion. In attempting to understand follicular carcinoma it is important to remember that its etiology, epidemiology, pathology, clinical features, pattern of growth and spread, prognosis, and response to various treatment modalities are different from other tumors in this group.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cuello C, Correa P, Eisenberg H. Georgraphic Pathology of thyroid carcinoma. Cancer 1969; 23: 230–239.
Williams ED. Pathology and natural history. In: Duncan W, ed. Thyroid Cancer. Vol. 73. Berlin: Springer-Verlag, 1980: 47–55.
Ingbar SH, Braverman LE. Werner’s The Thyroid: a Fundamental and Clinical Text. 5th ed. Philadelphia: J.B. Lippincott Company, 1986; 1329–1348.
Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating FR. Classification and prognosis of thyroid carcinoma: A study of 885 cases observed in a thirty year period. Am J Surg 1961; 102: 354–387.
Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: Impact of therapy in 214 patients. J Nucl Med 1980; 21: 733–737.
Olin RM. Iodine deficiency and prevalence of simple goiter in Michigan. JAMA 1924; 82: 1328–1332.
Brush BE, Atland JK. Goiter prevention with iodized salt: results of a thirty-year study. J Clin Endocrinol Metab 1952; 12: 1380–1388.
Beahrs OH, Pemberton J, Black BM. Nodular goiter and malignant lesions of the thyroid gland. J Clin Endocrinol Metab 1951;1157–1165.
Cuello C, Correa P, Eisenberg H. Geographic pathology of thyroid carcinoma. Cancer 1969; 23: 230–239.
Williams ED, Doriach I, Bjarnason O, Michie W. Thyroid cancer in an iodide rich area: A histopathological study. Cancer 1977; 39: 215–222.
Lindahl F. Follicular thyroid carinoma in Denmark 1943–1968. Danish Medical Bulletin 1976; 23: 107–119.
Hirabayaghi RN, Lindsay S. The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obst 1965; 121: 243–252.
Shapiro SJ, Friedman WB, Perzik SL, Catz B. Incidence of thyroid carcinoma in Graves’ disease. Cancer 1970; 26: 1261–1270.
Mazzaferri EL. Thyroid cancer and Graves’ disease. J Clin Endocrinol Metab 1990; 70: 826–829.
Belfiore A, Garofalo MR, Giuffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J Clin Endocrinal Metab 1990; 70: 830–837.
Stanbury, JB. Thyroid specific metabolic incompetence and tumor development. In: Hedinger CE, ed. Thyroid Cancer. Vol. 12. New York: Springer Verley, 1969: 183.
Cooper DS, Axelrod L, DeGroot LJ, Vickery AL, Maloof F. Congenital goiter and the development of metastic follicular carcinoma with evidence for a leak of non-hormonal iodide: Clinical, pathological, kinetic, and biochemical studies and a review of the literature. J Clin Endocrinol Metab 1981; 52: 294–306.
Riccabona G, Oberladstatter M, Fill H, Zechmann W, Fuchs D, Jenewein I. Incidence of thyroid cancer in families: Some case reports. Acta Endocrinol 1983. Suppl 252: 19.
Lloyd KM, Dennis M. Cowden’s Disease: a possible new complex with multiple system involvement. Ann Intern Med 1963; 58: 136–142.
Weary PE, Gorlln RJ, Gentry WC Jr, Comer JE, Green KE. Multiple hamartoma syndrome (Cowden’s disease). Arch Dermatol 1972; 106: 682–690.
Thompson NW, Nishiyama RH, Harness JK. Thyroid carinoma: Current controversies. In: Ravitch MM, Steicher FM, eds. Current problems in Surgery 15, No. 11. Chicago: Yearbook Medical Publishers, 1978: 1–15.
Cady B, Sedgwick CD, Meissner WA, Bookwalter JR, Romagosa V, Werber J. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976; 184: 541–553.
Boehm T, Rothouse L, Wartofsky L. Metastatic occult follicular thyroid carcinoma. JAMA 1976; 235: 2420–2421.
Goldberg LD, Ditchek NT. Thyroid carcinoma with spinal cord compression. JAMA. 1981; 245: 953–954.
McKonnon JK, Von Westap C, Mitchell R. Follicular carcinoma of the thyroid with functioning metastases and clinical hyperthyroidism. Can Med Assoc J 1975; 112: 724–727.
Sung LC, Cavalieri RR. T3 thyrotoxicosis due to metastatic thyroid carcinoma. J Endocrinol Metab 1973; 36: 215–217.
Schneider AB, Favus MJ, Stachura ME, et al. Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation. Ann Int Med 1977; 86: 29–34.
Bascheri L, Giani C, Taddei P, Lari R, Pinchera A. Serum thyroglobulin as a marker of thyroid carcinoma. In: Andreoli M, Monaco F, Robbins J (ed). Advances in Thyroid Neoplasia. 1981: 1182–1201.
Smith M, McHenry C, Jarosz H, Lawrence AM, Paloyan E. Carcinoma of the thyroid in patients with autonomous nodules. Am J Surg 1988; 54: 448–449.
Miyata Y, Sasaki T, Takaya K, Taguchi Y, Kasai M. New approach for diagnosis of malignant goiter using nuclear magnetic resonance. In: Medeiros-Neto G, Gaitan E, eds. Frontiers in Thyroidology. Vol. 2. New York: Plenum 1986: 1303–1307.
Galvan G. The value of the aspiration biopsy cytology for the diagnosis of thyroid malignancies. (Comparison of cytology and histology in 2744 patients with hypofunctional thyroid nodules) Acta Endocrinol 1983; 252: 55–56.
Nishiyama RH, Bigos ST, Goldfarb WB, Flynn SD, Taxiarchis LN. The efficacy of simultaneous fine needle aspiration and large-needle biopsy of the thyroid gland. Surgery 1986; 100: 1133–1137.
Lo Gerfo P, Starker P, Weber C, Moore D, Feind C. Incidence of cancer in surgically treated thyroid nodules based on method of selection. Surgery 1985; 98: 1197–1201.
Kung IT, Yuen RW. Fine needle aspiration of the thyroid. Distinction between colloid nodules and follicular neoplasms using cell blocks and 21-gauge needles. Acta Cytol 1989; 33: 53–60.
Gharib H, Goellner J, Zinsmeister AR, Grant CS, Van Heerden J A. Fine needle aspiration biopsy of the thyroid. Ann Int Med 1984; 101: 25–28.
Lang W, Georgii A, Stauch G, Kienzle E. The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Archiv 1980; 385: 125–141.
Hazard JB, Kenyon R. Atypical Adenoma of the Thyroid. Arch Pathol 1954; 58: 554–563.
Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurtle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974; 139: 555–560.
Flynn SD, Forman BH, Stewart AF, Kinder BK. Poorly differentiated (“insular”) carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery 1988; 104: 963–970.
Hedinger C, Soben LH. Histological typing of thyroid tumours. In: International Histological Classification of Thyroid Tumors. No. 11. WHO, 1974: 17.
Hedinger C. Histological typing of thyroid tumors. 2nd ed. Berlin, Springer-Verlag 1988: 1–34.
Franssila KO, Ackerman LV. Follicular carcinoma. Sem Diagn Pathol 1985; 2: 101–122.
Kahn NF, Perzin KH. Follicular carcinoma of the thyroid: An evaluation of the histologic criteria used for diagnosis. Pathol Annu 1983; 18 (Part l): 221–253.
Lang W, Georgii G. The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virch Arch Pathol 1980; 385: 125–141.
Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective followup study covering a 14 year period with emphasis on morphological findings. Am J Surg Pathol 1986; 10: 246–255.
Woolner LB. Thyroid carcinoma: Pathologic consideration with data on prognois. Sem Unci Med 1971; 1: 481–502.
Harach HR, Franssila KO. Thyroglobulin immunostaining in follicular thyroid carcinoma. Histopathology 1988; 13: 43–54.
Ryff de Leche A, Staub JJ, Kohler-Faden R, Muller-Brand J, Heitz PU. Thyroglobulin production by malignant thyroid tumors. An immunocytochemical and radioimmunoassay study. Cancer 1986; 57: 1145–1153.
Mizukami Y, Michigishi T, Nonomura A, et al. Distant metastases in differentiated thyroid carcinomas: A clinical and pathologic study. Hum Pathol 1990; 21: 283–290.
Joensu H, Klemi P, Eerola E. DNA aneuploidy in follicular adenomas of the thyroid gland. Am J Pathol 1986; 124: 373–376.
Johannessen JV, Sobrinho-Simoes M. Follicular carcinoma of the human thyroid gland. An ultrastructural study with emphasis on scanning electron microscopy. Diagn Histopathol 1982; 5: 113–127.
Lukacs GL, Balazs G, Zs-Nagy I. Cytoflourimetric measurements on the DNA contents of tumor cells in human thyroid gland. J Cancer Res Clin Oncol 1979; 95: 265–271.
Grant CS, Hay ID, Ryan JJ, Bergstrah EJ, Reunwater LM, Guillnar JR. Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World Jnl of Surgery, 1990; 14: 283–289.
Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 1987; 83: 479–488.
Cady B, Rossi R, Silverman M, Wool M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985; 98: 1171–1178.
Schmidt RJ, Wang CA. Encapsulated follicular carcinoma of the thyroid: diagnosis, treatment, and results. Surgery 1986; 100: 1068–1077.
Schlumberger M, Tubiana M, DeVathaire F, et al. Long term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. JCEM 1986; 63: 960–967.
Schlumberger M, DeVathaire F, Travagli JP, Vassal G, et al. Differentiated thyroid carcinoma in childhood: Long term follow–up of 72 patients. J Clin Endocrinol Metab 1987; 65: 1088–1094.
Tubiana M, Schlumberger M, Rougier P, et al. Long term results and prognostic factors in patient with differentiated thyroid carcinoma. Cancer 1985; 55: 794–804.
Brennan MD, Bergstrahl EJ, Van Heerden JA, McConahay WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946–1970: Initial manifestations, pathological findings, therapy and outcome. Mayo Clinic Proc. 1991; 66: 11–22.
Mazzaferri EL. Treating thyroid carcinoma: Where do we draw the line? Mayo Clinic Proc. 1991; 66: 105–111.
Woolner LB, Beahrs OH, Black BM. Classification and prognosis of thyroid carcinoma: A study of 885 cases observed in a thirty year period. Am J Surg 1961; 102: 354–387.
Brooks JR, Starnes HF, Brooks DC, Pekley JN. Surgical therapy for thyroid carcinoma: a review of 1249 solitary thyroid nodules, Surgery 1988; 104: 940–946.
Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients. J Clin Endocrinol Metab 1985; 60: 376–380.
Gundry SR, Burney RE, Thompson NW, Lloyd R. Total thyroidectomy for Hiirthle cell neoplasm of the thyroid. Arch Surg 1983; 118: 529–532.
Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H. Hiirthle cell and mitochondrion-rich cell tumors. A clinicopathologic study. Cancer 1986; 57: 1154–1163.
Tollefren HR, Shah JP, Huvos AG. Hurtle cell carcinoma of the thyroid. Am J Surg 1975; 130: 390–394.
Watson RG, Brennan MD, Goellner JR, McConahey WM, Taylor WF. Invasive Hurtle Cell Carcinoma of the Thyroid: Natural History and Management. Mayo Clin Proc 1984; 59: 851–855.
Bondeson L, Bondeson AG, Ljunberg O, Tibblin S. Oxyphil Tumors of the Thyroid: Follow-up of 42 Surgical Cases. Ann Surg 1981; 194: 677–680.
LiVolsi VA. Surgical pathology of the thyroid gland. Philadelphia: WB Saunders 1990; 193–212.
Har-El G, Hadar T, Segl K, Levy R, Sidi J. Hiirthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 1986; 57: 1613–1617.
Dobyns BM, Bertozzi G. Identification of cold nodules and surgical management of carcinoma of the thyroid. Ann Surg 1970; 172: 703–710.
Pochin EE. Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 1967; 18: 113.
Varma VM, Beierwaltes WH, Nofal MM, Nishiyama RH, Copp JE. Treatment of thyroid cancers: Death rates after surgery and after surgery followed by sodium iodide 1–131. JAMA 1970; 214: 1437–1442.
Spies WG, Wojtowicz CH, Spies SM, Shah AY, Zimmer AM. Value of post-therapy whole-body 1–131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose 1–131 therapy. Clin Nucl Med 1989; 14: 793–800.
Krishnamurthy GT, Blahd WH. Radioiodine 1–131 therapy in the management of thyroid cancer. Cancer 1977; 40: 195–202.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Fiedler, R.P. (1992). Follicular Carcinoma of the Thyroid. In: Cobin, R.H., Sirota, D.K. (eds) Malignant Tumors of the Thyroid. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9127-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9127-2_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9129-6
Online ISBN: 978-1-4613-9127-2
eBook Packages: Springer Book Archive